Cargando…

Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress

SIMPLE SUMMARY: The cellular mechanisms of drug resistance prevent the correct efficacy of the therapies used in various types of cancer and nanotechnology has been postulated as a possible alternative to avoid them. This review focuses on describing the different mechanisms of drug resistance and d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortíz, Raúl, Quiñonero, Francisco, García-Pinel, Beatriz, Fuel, Marco, Mesas, Cristina, Cabeza, Laura, Melguizo, Consolación, Prados, Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123136/ https://www.ncbi.nlm.nih.gov/pubmed/33923200 http://dx.doi.org/10.3390/cancers13092058

Ejemplares similares

Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
por: Gago, Lidia, et al.
Publicado: (2023)

The Antitumor Activity of Sodium Selenite Alone and in Combination with Gemcitabine in Pancreatic Cancer: An In Vitro and In Vivo Study
por: Doello, Kevin, et al.
Publicado: (2021)

Biomimetic Magnetoliposomes as Oxaliplatin Nanocarriers: In Vitro Study for Potential Application in Colon Cancer
por: Garcia-Pinel, Beatriz, et al.
Publicado: (2020)

The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview
por: Quiñonero, Francisco, et al.
Publicado: (2019)

Oxaliplatin–Biomimetic Magnetic Nanoparticle Assemblies for Colon Cancer-Targeted Chemotherapy: An In Vitro Study
por: Jabalera, Ylenia, et al.
Publicado: (2019)

In Vitro Efficacy of Extracts and Isolated Bioactive Compounds from Ascomycota Fungi in the Treatment of Colorectal Cancer: A Systematic Review
por: Luque, Cristina, et al.
Publicado: (2022)

Antibody-Functionalized Nanoformulations for Targeted Therapy of Colorectal Cancer: A Systematic Review
por: Cepero, Ana, et al.
Publicado: (2022)

Synthetic Circular miR-21 Sponge as Tool for Lung Cancer Treatment
por: Rama, Ana R., et al.
Publicado: (2022)

Active Biomolecules from Vegetable Extracts with Antitumoral Activity against Pancreas Cancer: A Systematic Review (2011–2021)
por: Mesas, Cristina, et al.
Publicado: (2022)

Cancer Stem Cells in Sarcomas: In Vitro Isolation and Role as Prognostic Markers: A Systematic Review
por: Chico, Maria Angeles, et al.
Publicado: (2023)

Antioxidant and Chemopreventive Activity of Protein Hydrolysates from Raw and Germinated Flour of Legumes with Commercial Interest in Colorectal Cancer
por: Fuel, Marco, et al.
Publicado: (2022)

Bengamide Analogues Show A Potent Antitumor Activity against Colon Cancer Cells: A Preliminary Study
por: García-Pinel, Beatriz, et al.
Publicado: (2020)

Circular Sponge against miR-21 Enhances the Antitumor Activity of Doxorubicin against Breast Cancer Cells
por: Rama, Ana R., et al.
Publicado: (2022)

Anemonia sulcata and Its Symbiont Symbiodinium as a Source of Anti-Tumor and Anti-Oxidant Compounds for Colon Cancer Therapy: A Preliminary In Vitro Study
por: Cabeza, Laura, et al.
Publicado: (2021)

Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment
por: García-Pinel, Beatriz, et al.
Publicado: (2019)

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression
por: Perazzoli, Gloria, et al.
Publicado: (2015)

Antitumor Effect of the Ethanolic Extract from Seeds of Euphorbia lathyris in Colorectal Cancer
por: Mesas, Cristina, et al.
Publicado: (2021)

Recent Trends in Nanomedicine-Based Strategies to Overcome Multidrug Resistance in Tumors
por: Khan, Muhammad Muzamil, et al.
Publicado: (2022)

Combining Olaparib and Ascorbic Acid on Nanoparticles to Enhance the Drug Toxic Effects in Pancreatic Cancer
por: Quiñonero, Francisco, et al.
Publicado: (2023)

Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications
por: Ortiz, Raúl, et al.
Publicado: (2021)

Nanomedicine: Application Areas and Development Prospects
por: Boulaiz, Houria, et al.
Publicado: (2011)

Antiproliferative, Antioxidant, Chemopreventive and Antiangiogenic Potential of Chromatographic Fractions from Anemonia sulcata with and without Its Symbiont Symbiodinium in Colorectal Cancer Therapy
por: Peña, Mercedes, et al.
Publicado: (2023)

Electrospun Nanofibers: Recent Applications in Drug Delivery and Cancer Therapy
por: Contreras-Cáceres, Rafael, et al.
Publicado: (2019)

Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance
por: Zhou, Lei, et al.
Publicado: (2018)

Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticles
por: Melguizo, Consolación, et al.
Publicado: (2015)

Proteomic biomarkers in body fluids associated with pancreatic cancer
por: Jimenez-Luna, Cristina, et al.
Publicado: (2018)

Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles
por: Cabeza, Laura, et al.
Publicado: (2015)

Multidrug Resistance Phenotype in the RMS‐GR Human Rhabdomyosarcoma Cell Line Obtained after Polychemotherapy
por: Prados, Jose, et al.
Publicado: (1999)

Modulation of MDR1 and MRP3 Gene Expression in Lung Cancer Cells after Paclitaxel and Carboplatin Exposure
por: Melguizo, Consolación, et al.
Publicado: (2012)

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
por: Oliver, Jaime Antonio, et al.
Publicado: (2014)

5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer
por: Ortiz, Raúl, et al.
Publicado: (2012)

Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment
por: Tanaka, Hiroyoshi Y., et al.
Publicado: (2023)

Nanomedicine-based multimodal therapies: Recent progress and perspectives in colon cancer
por: He, Yu-Chu, et al.
Publicado: (2023)

Circulating PTGS2, JAG1, GUCY2C and PGF mRNA in Peripheral Blood and Serum as Potential Biomarkers for Patients with Metastatic Colon Cancer
por: Jimenez-Luna, Cristina, et al.
Publicado: (2021)

Evaluating Metabolite-Based Biomarkers for Early Diagnosis of Pancreatic Cancer: A Systematic Review
por: Perazzoli, Gloria, et al.
Publicado: (2023)

Specific Colon Cancer Cell Cytotoxicity Induced by Bacteriophage E Gene Expression under Transcriptional Control of Carcinoembryonic Antigen Promoter
por: Rama, Ana R., et al.
Publicado: (2015)

Evaluation of poly (lactic-co-glycolic acid) nanoparticles to improve the therapeutic efficacy of paclitaxel in breast cancer
por: Cabeza, Laura, et al.
Publicado: (2022)

Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance
por: Greene, Michelle K., et al.
Publicado: (2021)

Nanomedicines for Overcoming Cancer Drug Resistance
por: Hu, Tingting, et al.
Publicado: (2022)

Gemcitabine-Loaded Magnetically Responsive Poly(ε-caprolactone) Nanoparticles against Breast Cancer
por: García-García, Gracia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k2fonjtgp9rm40bi6epcr3sq60